Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) EBITDA (2011 - 2026)

Updated

Grace Therapeutics' EBITDA came in at -$2.29 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$2.53 million a year earlier.

Analysis

Grace Therapeutics (GRCE) EBITDA (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Grace Therapeutics reported EBITDA of -$23.66 million; for FY2026 (ended Mar 31, 2026), it came in at -$11.07 million.

  • Going back by fiscal year, EBITDA was -$16.67 million in FY2025, -$12.84 million in FY2024, -$52.03 million in FY2023 and -$15.59 million in FY2022.
  • The fiscal Q2 2027 figure represents the highest quarterly EBITDA since fiscal Q2 2024.
  • Business Quant data shows GRCE's EBITDA at -$15.92 million (Q1 2027), -$3.01 million (Q4 2026) and -$2.45 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 8.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 8.16 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 5.99 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.20 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 7.05 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -2.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2.29 Mn
Jun 30, 2026 -15.92 Mn
Mar 31, 2026 -3.01 Mn
Dec 31, 2025 -2.45 Mn
Sep 30, 2025 -2.53 Mn
Jun 30, 2025 -3.09 Mn
Mar 31, 2025 -3.18 Mn
Dec 31, 2024 -3.70 Mn
Sep 30, 2024 -4.83 Mn
Jun 30, 2024 -4.96 Mn
Mar 31, 2024 -3.26 Mn
Dec 31, 2023 -3.04 Mn
Sep 30, 2023 -2.09 Mn
Jun 30, 2023 -4.45 Mn
Mar 31, 2023 -38.07 Mn
Dec 31, 2022 -4.24 Mn
Sep 30, 2022 -5.17 Mn
Jun 30, 2022 -4.56 Mn
Mar 31, 2022 -4.40 Mn
Dec 31, 2021 -4.47 Mn
API Access

Grace Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=GRCE&period=max&api_key=YOUR_API_KEY